Kenvue
€10,000 invested in 2023 · with dividend reinvestment
Dividend history
About Kenvue
Kenvue is the consumer-health company spun off from Johnson & Johnson, home to household names such as Tylenol, Band-Aid, Listerine, Neutrogena and Aveeno. It holds leading positions in over-the-counter medicines, skin health and personal care, categories that are generally stable but competitive and sensitive to consumer spending and private-label pressure. As a recently independent company, Kenvue has only a short dividend history, though it launched its payout at a meaningful level, giving it a moderate yield from the start. Its dividend-focused score is held back by the brief track record and the litigation and margin questions the business faces. The distribution looks affordable, but investors have limited history to judge its consistency and growth potential.